Search results
Bill would bar wearing a mask in North Carolina. How will that affect people with medical conditions...
Winston-Salem Journal· 2 days agoA ban on wearing a mask publicly in North Carolina, even during such emergencies as the recent...
Insider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson ...
GuruFocus.com via Yahoo Finance· 7 days agoThe transaction was filed on the same day with the SEC. Cullinan Therapeutics Inc (NASDAQ:CGEM)...
iTeos Therapeutics announces $120 million stock sale By Investing.com
Investing.com· 6 days agoWATERTOWN, Mass. and GOSSELIES, Belgium - iTeos Therapeutics, Inc. (NASDAQ:ITOS), a...
Q1 2024 Singular Genomics Systems Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 14 hours agoTurning to our focus areas for the rest of 2024 for our internal focus is centered around developing the G. four X platform and optimizing the spatial sequencing methods and protocols initially ...
UF Health scientists make breakthrough in possible cancer treatment
The Gainesville Sun· 1 day agoThe University of Florida has developed a preliminary vaccine that may give a patient's immune...
UC San Diego study finds plant virus may slow the progression of cancer
KSWB articles via Yahoo News· 1 day agoThe research was conducted by UC San Diego researchers led by Professor Nicole Steinmetz, director...
Guggenheim downgrades Bolt Biotherapeutics stock amid leading drug halt By Investing.com
Investing.com· 16 hours agoOn Wednesday, Guggenheim Securities adjusted its stance on Bolt Biotherapeutics, Inc. (NASDAQ:BOLT),...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WJTV Jackson· 20 hours agoTotal operating revenues in Q1 2024 amounted to $6.4M, compared to $4.3M in Q1 2023. As of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt ...
AnaptysBio reports positive phase 3 GPP trial results By Investing.com
Investing.com· 6 days agoAnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stagebiotechnology company, announced positive results...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 2 days agoThe drug is being studied for more than 30 types of cancer, including both monotherapy and...
